Earlier this month the FDA approved Keytruda, manufactured by Merck, to treat melanoma. Keytruda disrupts the cancer cells that tell the body's immune system not to attack the cancer cells as intruders. Keytruda, and other drugs in this class are already being tested...
The U.S. Senate unanimously passed Senate resolution 66 designating the first week of April 2013 as "National Asbestos Awareness Week." Asbestos is known to cause lung cancer and mesothelioma by breathing in asbestos fibers that become lodged in the lung or lining of...
Patients now have better treatment options to increase their survival rates through the use of advanced treatment options. Patients with pleural mesothelioma have two surgical options both of which are painful and difficult for the patients. The doctor may...
Patients suffering from mesothelioma, lung cancer, and other solid tumors may be eligible to participate in clinical trials at the National Cancer Institute (NCI) in Bethesda Maryland involving the use of immunotherapy agents which target the tumor antigen mesothelin....
Last week researchers reported that another important biomarker has been identified for treating mesothelioma and lung cancer patients. Researchers have discovered that the fibroblast growth-inducible 14 (FN14) gene plays a role in tumor growth and metastasis. When...
Subscribe To This Blog’s Feed